Squarepoint
NUTX

Squarepoint’s Nutex Health NUTX Stock Holding History

Squarepoint’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,624
Closed -$597K – 4735
2025
Q4 		$597K Sell
3,624
-1,932
-35% -$256K ﹤0.01% 3065
2025
Q3 		$574K Buy
5,556
+3,668
+194% +$360K ﹤0.01% 3131
2025
Q2 		$235K Sell
1,888
-8,046
-81% -$1.04M ﹤0.01% 3870
2025
Q1 		$467K Buy
9,934
+948
+11% +$46.3K ﹤0.01% 3374
2024
Q4 		$285K Buy
+8,986
New +$256K ﹤0.01% 4190
2024
Q1 		– Sell
-188
Closed -$5.08K – 4421
2023
Q4 		$5.08K Buy
+188
New +$5.86K ﹤0.01% 3936
2023
Q2 		– Sell
-1,009
Closed -$153K – 3866
2023
Q1 		$153K Buy
1,009
+847
+523% +$172K ﹤0.01% 2885
2022
Q4 		$46.3K Buy
+162
New +$31.1K ﹤0.01% 3064

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Squarepoint's NUTX Position: Q1 2026 in Review

Squarepoint sold out of Nutex Health (NUTX) in Q1 2026, closing a stake of 3,624 shares — an estimated $597K sold.

Squarepoint first reported a position in NUTX in Q4 2022 and held it in 8 quarters. The position peaked at $597K in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Squarepoint reported no remaining Nutex Health position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 3,624 Nutex Health shares in Q1 2026, an estimated $597K.
  • Squarepoint first reported a position in Nutex Health in Q4 2022 and held it in 8 quarters.
  • Squarepoint's Nutex Health position peaked at $597K in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.